September - 2023

Companies in the News

Sep 28, 2023

Gritstone bio Awarded BARDA Contract to Conduct Comparative Phase 2b Study

10,000 participant randomized Phase 2b study will evaluate Gritstone’s self-amplifying mRNA (samRNA) vaccine candidate containing Spike...

Sep 14, 2023

Generate:Biomedicines Announces Close of $273M Series C Financing

Funding will advance pipeline of 17 existing programs and approximately 10 new starts annually Company has raised nearly $700 million in...